Dupilumab Improves Symptoms and Quality of Life in Pediatric Patients With Moderate-to-Severe Atopic Dermatitis in Clinical Practice: RELIEVE-AD-PED Study. (2026). SKIN The Journal of Cutaneous Medicine, 10(2), s737. https://doi.org/10.25251/0y59xj91